We have a strategic focus on neuroinflammation which is increasingly recognized as critically involved in multiple brain disorders.

We are committed to deliver novel therapies that modulate neuroinflammatory mechanisms and restore balance to the brain to unlock new possibilities for patients with a central nervous system condition.

We search, evaluate and integrate the most promising European projects to build and advance a leading portfolio of balanced risk/reward assets in neurology. We are neuroscience innovators with a creative model structured to efficiently turn breakthrough science into therapeutic solutions targeting the underpinning causes of disease.